Confluent, Inc. filings document the company's transition from a Nasdaq-listed public company with Class A common stock under CFLT to a private company following its completed merger with International Business Machines Corporation. The formal record includes Form 8-K material-event reports on the merger closing, shareholder voting matters, governance changes and operating results, along with Form 25 delisting and Form 15 termination of Exchange Act registration and reporting duties.
Earlier disclosure categories for Confluent addressed material agreements, capital-structure matters, officer governance events and financial results associated with its data streaming software business.
Confluent, Inc. director Eric Vishria, through entities he controls, reported an open-market sale of 61,905 shares of Class A common stock on February 13, 2026 at an average price of $30.57 per share under a pre-arranged 10b5-1 trading plan. After this indirect sale, entities he controls held 663,637 shares, and he also reported 20,861 shares held directly.
CFLT-related Form 144: Proposed and recent insider sales reported by a broker and an individual. The filing lists two planned sales of common stock associated with an Employee Stock Purchase Plan on 02/13/2026 (1,398 shares) and 08/15/2025 (715 shares). It also lists multiple sales by Ryan Mac Ban during the preceding three months: 12/23/2025 3,053 shares for $91,470.93; 12/22/2025 1,218 shares for $36,487.75; 12/08/2025 44,114 shares for $1,313,273.78; and two trades on 11/20/2025 of 10,145 shares for $228,316.27 and 4,917 shares for $110,658.56.
Confluent, Inc. (CFLT) received an amended Schedule 13G filing from Point72 entities and Steven A. Cohen reporting beneficial ownership of 183,700 shares of Class A common stock, or 0.1% of the class, as of December 31, 2025.
The reported position represents shares issuable upon exercise of call options held by an investment fund managed by Point72 Asset Management, with voting and investment power shared among Point72 Asset Management, Point72 Capital Advisors, Inc., and Cohen. The filers state they directly own no Confluent Class A shares and disclaim being beneficial owners for certain legal purposes.
They also certify the securities were not acquired, and are not held, to change or influence control of Confluent, indicating a passive investment-style filing rather than an activist position.
A holder of CFLT common stock has filed a Rule 144 notice to sell 60,000 shares through Morgan Stanley Smith Barney LLC on or around February 13, 2026 on the NASDAQ market. The filing lists an aggregate market value of 1831200.00 for this block and notes that 308,661,566 shares of this class were outstanding.
The 60,000 shares were acquired on September 16, 2014 via an in-kind distribution post‑IPO from the issuer, with no separate cash payment. The filing also details recent Rule 10b5‑1 plan sales by related trusts, including blocks of 15,000 shares for proceeds of about 450000.00 and 447600.00.
Confluent insider plans a sizable stock sale under Rule 144. A holder of Confluent common stock filed notice to sell 640,000 shares through Morgan Stanley Smith Barney, with an aggregate market value of $19,532,800.00. These shares are part of the company’s common stock listed on NASDAQ, with 308,661,566 shares outstanding.
The shares to be sold were acquired as founder shares from the issuer on 09/01/2014. The filing also lists recent Rule 10b5-1 plan sales of Confluent common stock over the past three months by related parties, showing multiple transactions with individual gross proceeds ranging from about $664,590.00 to $10,000,990.00.
Confluent insider plans to sell common stock under Rule 144. A holder filed to sell 80,000 shares of Confluent common stock through Morgan Stanley Smith Barney, with an aggregate market value of $2,441,600.00. Confluent had 308,661,566 shares outstanding as of this notice.
The shares to be sold were acquired by exercising stock options on 02/13/2026, paid in cash on the same date. The notice also lists multiple recent Rule 10b5-1 plan sales of Confluent common stock over the prior three months by related holders, showing ongoing, pre-arranged selling activity.
CFLT received a Form 144 notice covering a proposed sale of restricted or control 120,000 shares of common stock, with an aggregate market value of 3662400.00. The shares are expected to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ, with an approximate sale date of 02/13/2026. The filing shows 308,661,566 shares of this class outstanding.
The seller acquired these shares as Founders Shares from the issuer on 09/01/2014. The notice also summarizes recent Rule 10b5-1 planned sales in the past three months by related holders, including entities and individuals at the same address, with multiple transactions in December 2025. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer.
A holder associated with CFLT has filed a Rule 144 notice to sell 25,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about 02/13/2026 on NASDAQ, with an aggregate market value of $763,000. These shares were acquired on 02/03/2023 via a distribution from Index Ventures. The notice also reports prior Rule 10b5-1 sales on 12/08/2025, including 32,038 common shares for Michelangelo Volpi for gross proceeds of $953,883.39 and 17,962 common shares for the Volpi-Cupal Family Trust for gross proceeds of $534,791.61.
A shareholder of CFLT has filed a Form 144 notice to potentially sell 1,905 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of 58140.60 and an approximate sale date of 02/13/2026.
The shares were acquired on 09/26/2014 via an in-kind distribution post-IPO from the issuer. Over the past three months, 10b5-1 plan sales for The Vishria Revocable Trust and The Khakal Trust included 15,000-share transactions on 12/10/2025 and 12/08/2025 with gross proceeds of 450000.00 and 447600.00, plus 476-share sales on the same dates with proceeds of 14280.00 and 14203.84. The signing party represents they do not know any undisclosed material adverse information about the issuer.
Ryan Mac Ban has filed a notice relating to the planned sale of 1,655 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. The aggregate market value of these shares is listed as $50,510.60, with 308,661,566 shares of this class outstanding.
The 1,655 shares to be sold were acquired on 12/20/2025 as restricted stock units from the issuer, with payment on the same date. Over the prior three months, the document lists additional common stock sales for Ryan Mac Ban, including 3,053 shares for $91,467.88 on 12/23/2025, 1,218 shares for $36,491.28 on 12/22/2025, 44,114 shares for $1,313,489.94 on 12/08/2025 noted as “10b5-1 Sales,” and 15,062 shares for $339,045.62 on 11/20/2025.